| 000 | 01872 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514205413.0 | ||
| 264 | 0 | _c20041108 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a1369-7137 | ||
| 024 | 7 |
_a10.1080/13697130410001713724 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWierik, E J M Velthuis-te | |
| 245 | 0 | 0 |
_aClinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study. _h[electronic resource] |
| 260 |
_bClimacteric : the journal of the International Menopause Society _cJun 2004 |
||
| 300 |
_a197-209 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrug Utilization |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 |
_aEstrogen Receptor Modulators _xsupply & distribution |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorgestrel _xadministration & dosage |
| 650 | 0 | 4 |
_aNorpregnenes _xsupply & distribution |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aHendricks, P T | |
| 700 | 1 | _aBoerstoel-Streefland, M | |
| 773 | 0 |
_tClimacteric : the journal of the International Menopause Society _gvol. 7 _gno. 2 _gp. 197-209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/13697130410001713724 _zAvailable from publisher's website |
| 999 |
_c15187454 _d15187454 |
||